KR100760983B1 - A red pepper paste added garlic and its making method - Google Patents
A red pepper paste added garlic and its making method Download PDFInfo
- Publication number
- KR100760983B1 KR100760983B1 KR1020060074668A KR20060074668A KR100760983B1 KR 100760983 B1 KR100760983 B1 KR 100760983B1 KR 1020060074668 A KR1020060074668 A KR 1020060074668A KR 20060074668 A KR20060074668 A KR 20060074668A KR 100760983 B1 KR100760983 B1 KR 100760983B1
- Authority
- KR
- South Korea
- Prior art keywords
- garlic
- pepper paste
- mixing
- red pepper
- weight
- Prior art date
Links
- 240000002234 Allium sativum Species 0.000 title claims abstract description 138
- 235000004611 garlic Nutrition 0.000 title claims abstract description 138
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 title claims abstract description 37
- 240000004160 Capsicum annuum Species 0.000 title claims abstract description 35
- 235000007862 Capsicum baccatum Nutrition 0.000 title claims abstract description 35
- 239000001728 capsicum frutescens Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 34
- 238000004519 manufacturing process Methods 0.000 claims abstract description 31
- 235000000346 sugar Nutrition 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 18
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 235000019629 palatability Nutrition 0.000 claims abstract description 17
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 14
- 230000001093 anti-cancer Effects 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 235000002566 Capsicum Nutrition 0.000 claims description 60
- 239000006002 Pepper Substances 0.000 claims description 60
- 241000722363 Piper Species 0.000 claims description 60
- 235000016761 Piper aduncum Nutrition 0.000 claims description 60
- 235000017804 Piper guineense Nutrition 0.000 claims description 60
- 235000008184 Piper nigrum Nutrition 0.000 claims description 60
- 238000002156 mixing Methods 0.000 claims description 31
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims description 29
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims description 29
- 235000010081 allicin Nutrition 0.000 claims description 29
- 230000008569 process Effects 0.000 claims description 22
- 235000021395 porridge Nutrition 0.000 claims description 19
- 229920002472 Starch Polymers 0.000 claims description 18
- 235000019698 starch Nutrition 0.000 claims description 18
- 239000008107 starch Substances 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 16
- 239000004475 Arginine Substances 0.000 claims description 13
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 13
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 12
- 206010020772 Hypertension Diseases 0.000 claims description 12
- 230000001965 increasing effect Effects 0.000 claims description 12
- 229940010454 licorice Drugs 0.000 claims description 12
- 241000202807 Glycyrrhiza Species 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000002568 Capsicum frutescens Nutrition 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 230000005070 ripening Effects 0.000 claims description 4
- 230000036737 immune function Effects 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 240000008574 Capsicum frutescens Species 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 3
- 235000010469 Glycine max Nutrition 0.000 abstract description 2
- 244000068988 Glycine max Species 0.000 abstract description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 2
- 240000005979 Hordeum vulgare Species 0.000 abstract 2
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 2
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 229910052571 earthenware Inorganic materials 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 17
- 229940024606 amino acid Drugs 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 17
- 235000013305 food Nutrition 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 235000009697 arginine Nutrition 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 235000019155 vitamin A Nutrition 0.000 description 8
- 239000011719 vitamin A Substances 0.000 description 8
- 229940045997 vitamin a Drugs 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 238000004949 mass spectrometry Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 4
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 4
- 229930003451 Vitamin B1 Natural products 0.000 description 4
- NAXKFVIRJICPAO-LHNWDKRHSA-N [(1R,3S,4R,6R,7R,9S,10S,12R,13S,15S,16R,18S,19S,21S,22S,24S,25S,27S,28R,30R,31R,33S,34S,36R,37R,39R,40S,42R,44R,46S,48S,50R,52S,54S,56S)-46,48,50,52,54,56-hexakis(hydroxymethyl)-2,8,14,20,26,32,38,43,45,47,49,51,53,55-tetradecaoxa-5,11,17,23,29,35,41-heptathiapentadecacyclo[37.3.2.23,7.29,13.215,19.221,25.227,31.233,37.04,6.010,12.016,18.022,24.028,30.034,36.040,42]hexapentacontan-44-yl]methanol Chemical compound OC[C@H]1O[C@H]2O[C@H]3[C@H](CO)O[C@H](O[C@H]4[C@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@H]6[C@H](CO)O[C@H](O[C@H]7[C@H](CO)O[C@@H](O[C@H]8[C@H](CO)O[C@@H](O[C@@H]1[C@@H]1S[C@@H]21)[C@@H]1S[C@H]81)[C@H]1S[C@@H]71)[C@H]1S[C@H]61)[C@H]1S[C@@H]51)[C@H]1S[C@@H]41)[C@H]1S[C@H]31 NAXKFVIRJICPAO-LHNWDKRHSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- UBAXRAHSPKWNCX-UHFFFAOYSA-N diallyl trisulfide Chemical compound C=CCSSSCC=C UBAXRAHSPKWNCX-UHFFFAOYSA-N 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000021309 simple sugar Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- -1 sugar Chemical class 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000021310 complex sugar Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- QFQWGVXXWLRQNK-UHFFFAOYSA-N 2,4-dinitrophenol;hydrazine Chemical compound NN.OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O QFQWGVXXWLRQNK-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- RMKCQUWJDRTEHE-UHFFFAOYSA-N Diallyltetrasulfane Chemical compound C=CCSSSSCC=C RMKCQUWJDRTEHE-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241001247145 Sebastes goodei Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 239000002956 ash Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000005772 leucine Nutrition 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 235000008729 phenylalanine Nutrition 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000001754 3-prop-2-enyldisulfanyldisulfanylprop-1-ene Substances 0.000 description 1
- YCPXWRQRBFJBPZ-UHFFFAOYSA-N 5-sulfosalicylic acid Chemical compound OC(=O)C1=CC(S(O)(=O)=O)=CC=C1O YCPXWRQRBFJBPZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 108010021511 Aspergillus oryzae carboxyl proteinase Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229930189603 alysine Natural products 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001064 anti-interferon Effects 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DAMJCWMGELCIMI-UHFFFAOYSA-N benzyl n-(2-oxopyrrolidin-3-yl)carbamate Chemical compound C=1C=CC=CC=1COC(=O)NC1CCNC1=O DAMJCWMGELCIMI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000007593 dry painting process Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940071264 lithium citrate Drugs 0.000 description 1
- WJSIUCDMWSDDCE-UHFFFAOYSA-K lithium citrate (anhydrous) Chemical compound [Li+].[Li+].[Li+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WJSIUCDMWSDDCE-UHFFFAOYSA-K 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019624 protein content Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/70—Germinated pulse products, e.g. from soy bean sprouts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/212—Garlic
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
도 1은 본 발명인 마늘고추장의 재료준비단계와 제조단계의 흐름도.1 is a flow chart of the material preparation step and manufacturing step of the present inventors garlic pepper paste.
도 2는 본 발명인 마늘고추장의 질량분석(GC-MASS) 스펙트럼 결과도Figure 2 is a mass spectrometry (GC-MASS) spectrum of the garlic pepper paste of the present invention
본 발명은 마늘고추장 및 그의 제조방법에 관한 것으로, 고추장의 주 원료가 되는 마늘의 유익한 성분을 최대한 유지하기 위하여 마늘을 선별하고 수세 및 분쇄하여 80~100°C에서 증자 처리하여 마늘죽을 제조하는 마늘죽 제조단계인 1공정과: 마늘죽에 미리 준비한 엿질금을 혼합하는 1차 혼합단계의 2공정과: 1차 혼합단계를 거친 원료를 증자 처리하는 증자 단계의 3공정과: 증자된 원료에 고춧가루와 메주가루를 첨가하여 혼합하고 간 조절을 위하여 소금을 혼합하는 2차 혼합단계의 4공정과: 2차 혼합단계까지 혼합되어진 원료에 감초, 치자, 홍화를 혼합하여 기호성 조절을 하게 되는 기호성조절단계의 5공정과: 기호성 조절단계 후, 전통옹기에 넣어 상온에서 숙성시키는 숙성단계의 6공정의 과정을 거쳐 제조 되어지는 것으로, 당 함량이 낮은 기능성 고추장과 아르기닌(arginine)의 함량증대로 면역 기능 증강 등, 항암, 고혈압 및 혈당 개선효과가 높은 마늘 유래 설파이드계 화합물이 함유되어 있는 것을 특징으로 하는 마늘고추장 및 그의 제조방법에 관한 것이다. The present invention relates to a garlic pepper paste and its manufacturing method, in order to maintain the most beneficial ingredients of garlic, which is the main raw material of gochujang, the garlic is selected, washed with water and pulverized to increase the garlic at 80 to 100 ° C to prepare garlic porridge. Step 1, which is a step of making porridge: Step 2 of the first mixing step of mixing the prepared malt with garlic porridge, and step 3 of the cooking step of increasing the raw material after the first mixing step: with red pepper powder Fourth step of the second mixing step of adding and mixing the meju powder and salt for liver control: The palatability control step of controlling palatability by mixing licorice, gardenia and safflower with the raw materials mixed up to the second mixing step. 5th process: After the palatability control step, it is manufactured through the 6th process of the ripening step which is put into traditional pottery and aged at room temperature. The present invention relates to a garlic pepper paste and a method for preparing the same, which include a garlic-derived sulfide-based compound having high anti-cancer, high blood pressure, and blood sugar improving effects such as increased content of red pepper paste and arginine.
일반적으로, 고추장은 간장, 된장과 더불어 우리나라 고유의 장류식품 중 하나로 사용되는 재료에서 기인한 특유의 맛이 잘 조화를 이루는 기호식품이며, 숙성과정을 거치면서 맛이 더욱 깊어지는 발효식품이기도 하다. 게다가 고추장은 맛 뿐 아니라 여러 가지 아미노산, 비타민 등과 같은 영양성분들도 함유되어 있어 영양학적으로도 가치가 높은 식품이다. 최근 소득 수준의 향상과 함께 건강에 대한 관심이 높아지면서 식품에 대한 사람들의 인식은 단순히 생명현상 유지를 위한 영양공급원이라는 단순한 의미에서 벗어나 식품이 가지고 있는 기능에 주목하고 있다. 이른바 노화의 예방이나 방지 또는 약화된 건강기능의 회복을 위해 목적에 맞는 식품을 가능한 많이 섭취하려는 경향을 나타내고 있다. 그 결과 지난 십여 년 동안 대단히 많은 특정기능을 가진 건강기능식품들이 소개되어 왔고 판매되고 있는 실정이다. 고추장도 이러한 추세를 따라 각종 건강기능성을 가진 식품재료를 첨가한 제품들이 제조되어 지고 있다.In general, gochujang is a favorite food that harmonizes with the soy sauce, miso, and the unique flavors derived from the ingredients used as one of Korean's indigenous foods, and is also a fermented food that deepens the taste through the aging process. In addition, gochujang is not only delicious but also contains various nutrients such as amino acids and vitamins. With the recent increase in income levels and the growing interest in health, people's perception of food is focusing on the function of food beyond the simple meaning of being a nutritional source for maintaining life. There is a tendency to eat as much food as possible for the purpose of preventing or preventing aging or restoring weakened health function. As a result, health functional foods with a large number of specific functions have been introduced and sold in the last decade. Gochujang has also been manufactured with products added with various health functional ingredients.
최근 마늘이 자양강장효과, 고혈압 및 당뇨 개선, 해독작용 등이 우수하다는 결과들이 보고 되면서 마늘의 소비가 늘어나고 있으나 마늘은 알리인이라는 물질을 함유하고 있는데 이것이 공기 중 산소와 반응하여 알리신으로 변하면서 특유의 강한 향과 맛을 내게 된다. 이점이 건강에 유익하지만 마늘을 많이 섭취하기 어렵도록 하는 원인이 되고 있다.Recently, garlic has been reported to be excellent in nourishing tonic effect, improving hypertension and diabetes, and detoxifying effect. However, garlic consumption is increasing. However, garlic contains a substance called allicin, which is transformed into allicin by reacting with oxygen in the air. Its strong aroma and taste. This is good for your health, but it also makes it harder for you to eat more garlic.
한편 종래의 고추장은 그 원료로 쌀을 이용하고 있는데 쌀은 전분이 주성분 이고 다당류인 전분은 숙성과정을 거치면서 단당으로 분해되어 당질이 높아지며, 염이 과량 함유되어 있어 건강상 해로운 점도 있는 바, 이러한 다량 함유된 염에 따른 부작용을 감소시킬 수 있는 대안이 요구되어 왔으며, 고염의 섭취로 인하여 나타날 수 있는 고혈압증, 신장병, 심질환 등 순환기계에 대하여 나쁜 영향을 미치는 것으로 성인병 발명에 큰 문제점으로 대두되고 있다.Meanwhile, conventional kochujang uses rice as its raw material. Starch, which is a main ingredient and starch, which is a polysaccharide, is decomposed into monosaccharides during the aging process, has high sugar content, and contains excessive salt, which is harmful to health. There has been a need for an alternative that can reduce the side effects of salts in large amounts.It has been a major problem in the invention of adult diseases because it adversely affects the circulatory system, such as hypertension, kidney disease, and heart disease, which may be caused by high salt consumption. .
또한, 고추장의 기능 외에 특이한 기능성을 가진 웰빙 장류의 개발이 시급함에도 불구하고, 현재 까지는 별다른 기능성을 가진 고추장의 개발에 성과를 기대하기 어려운 문제점등이 있어왔다.In addition, despite the urgent need for the development of well-being soy sauce with unusual functionality in addition to the function of kochujang, there have been problems such as difficult to expect results in the development of kochujang with different functionalities.
본 발명은 상기 설명한 바와 같은 종래 기술의 문제점을 더욱 효율적으로 해결하기 위하여 제공된 것으로서, 마늘의 고유의 성분 및 건강기능 효과를 최대한 극대화 하면서 전분을 사용하지 않음으로 인한 당 함량과 염이 낮은 기능성 고추장과 아르기닌(arginine)의 함량증대로 면역 기능 증강 등, 항암, 고혈압 및 혈당 개선효과가 높은 마늘 유래 설파이드계 화합물이 함유되어 있는 것을 특징으로 하여 기호성과 건강기능성을 겸비한 웰빙 식품으로서의 마늘고추장을 공급하는데 그 목적이 있다.The present invention is provided to more efficiently solve the problems of the prior art as described above, while maximizing the intrinsic ingredients and health functional effects of garlic while maximizing the sugar content and salt due to the use of low functional kochujang and Garlic pepper paste as a well-being food that combines palatability and health function is characterized by containing garlic-derived sulfide-based compounds with high anti-cancer, high blood pressure, and high blood sugar improving effects, such as increasing the function of arginine and enhancing immune function. There is a purpose.
본 발명은 마늘고추장 및 그의 제조방법에 관한 것으로, 고추장의 주 원료가 되는 마늘의 유익한 성분을 최대한 유지하기 위하여 마늘을 선별하고 수세 및 분쇄하여 80~100°C에서 증자 처리하여 마늘죽을 제조하는 마늘죽 제조단계인 1공 정과: 마늘죽에 미리 준비한 엿질금을 혼합하는 1차 혼합단계의 2공정과: 1차 혼합단계를 거친 원료를 증자 처리하는 증자 단계의 3공정과: 증자된 원료에 고춧가루와 메주가루를 첨가하여 혼합하고 간 조절을 위하여 소금을 혼합하는 2차 혼합단계의 4공정과: 2차 혼합단계까지 혼합되어진 원료에 감초, 치자, 홍화를 혼합하여 기호성 조절을 하게 되는 기호성조절단계의 5공정과: 기호성 조절단계 후, 전통옹기에 넣어, 상온에서 숙성시키는 숙성단계의 6공정의 과정을 거쳐 제조 되어지는 것으로, 당 함량이 낮은 기능성 고추장과 아르기닌(arginine)의 함량증대로 면역 기능 증강 등, 항암, 고혈압 및 혈당 개선효과가 높은 마늘 유래 설파이드계 화합물이 함유되어 있는 것을 특징으로 하는 마늘고추장 및 그의 제조방법에 관한 것이다. The present invention relates to a garlic pepper paste and its manufacturing method, in order to maintain the most beneficial ingredients of garlic, which is the main raw material of gochujang, the garlic is selected, washed with water and pulverized to increase the garlic at 80 to 100 ° C to prepare garlic porridge. 1 process of porridge manufacturing process: 2 steps of the 1st mixing step of mixing the prepared malt of garlic porridge and 3 steps of the cooking step of increasing the raw material after the 1st mixing step: red pepper powder and Fourth step of the second mixing step of adding and mixing the meju powder and salt for liver control: The palatability control step of controlling palatability by mixing licorice, gardenia and safflower with the raw materials mixed up to the second mixing step. 5th process: After the palatability control step, it is manufactured through the 6th process of the ripening step that is put into traditional pottery and aged at room temperature. The present invention relates to a garlic red pepper paste and a method for preparing the same, which include a garlic-derived sulfide-based compound having high anti-cancer, high blood pressure, and blood sugar improving effects such as an increase in the content of sex kochujang and arginine.
이하, 본 발명의 구성을 도 1에 나타낸 구체적인 방법과 실시예를 들어 상세히 설명하면,Hereinafter, the configuration of the present invention in detail with reference to the specific method and embodiment shown in FIG.
도 1은 본 발명인 마늘고추장의 재료준비단계와 고추장 제조단계의 흐름도를 나타낸 것으로, 이를 더욱 상세하게 설명하면, 재료준비단계와 마늘고추장 제조단계로 나누어 구분되어지며, 먼저 재료 준비단계에서는 1공정에서의 마늘죽 제조공정으로 마늘의 유익한 성분을 최대한 유지하기 위하여 도시한 흐름도와 같이 각 과정의 단계를 거쳐 마늘죽이 제조되어 지며, Figure 1 shows a flow chart of the material preparation step and red pepper paste manufacturing step of the garlic pepper paste of the present invention, when described in more detail, are divided into a material preparation step and a garlic pepper paste manufacturing step, in the first step in the material preparation step Garlic porridge is manufactured through the steps of each process as shown in the flow chart in order to maintain the beneficial ingredients of garlic as the garlic porridge manufacturing process of
마늘고추장 제조단계에서는 준비된 마늘죽과 엿질금과의 1차 혼합하게 되는 2공정, 엿질금과 혼합되어진 마늘죽을 80°C에서 증자하게 되는 3공정, 고춧가루 및 메주가루를 첨가하여 2차 혼합하여 소금으로 간 조절하게 되는 4공정, 감초, 치 자, 홍화를 혼합하여 기호성 조절을 하게 되는 5공정, 제조된 고추장을 상온에서 숙성하게 되는 6공정을 거쳐 제조되어지는 것을 특징으로 하는 마늘 고추장의 제조방법에 관한 것이다.In the manufacturing process of garlic pepper paste, the first step of mixing the prepared garlic porridge with malt gold, the third step of increasing the garlic porridge mixed with malt gold at 80 ° C, adding red pepper powder and meju powder, and then mixing it with salt Four processes to be controlled, licorice, gardenia, safflower mixed with five steps to adjust the palatability, the prepared kochujang is made through six steps to ripen at room temperature will be.
상기 도 1 은 본 발명인 마늘고추장의 제조과정을 각 공정별로 상세하게 설명하면 다음과 같다.1 is described in detail for each process the manufacturing process of the garlic pepper paste of the present invention as follows.
[실시예 1] 재료 준비단계 및 마늘 고추장 제조단계 Example 1 Material Preparation Step and Garlic Gochujang Preparation Step
1. 기본 재료의 제조방법1. Manufacturing method of basic material
재료의 제조단계인 1공정에서는, 증자 처리를 하기 전 알리신이 충분히 생성되도록 유도한 후 증자하여 마늘죽으로 제조하기 위하여 마늘을 분쇄하여 공기와 접촉하는 표면적을 증가시켜 알리나제와 산소의 접촉을 촉진시킴으로서 알리신의 생성을 최대화 하기 위하여 먼저 마늘을 선별하여 마늘의 껍질을 제거한 후 깨끗이 세척(수세)하여 물기를 제거한 다음, 분쇄기로 분쇄하여 알리신이 충분히 생성되도록 유도한 후에 분쇄한 마늘을 80mesh 체로 곱게 거른 후 80~100℃에서 30분간 나무주걱으로 저어주면서 증자하여 마늘 죽을 제조하는 공정이다.In the first step, the manufacturing process of the material, induces sufficient allicin before increasing the steaming process, and then increases the surface area in contact with air by crushing garlic to increase the amount of allicin to make garlic porridge. In order to maximize the production of allicin, garlic is first screened to remove garlic peel, then washed (washed) to remove water, and then crushed with a grinder to induce sufficient production of allicin. After stirring for 30 minutes with a wooden spatula at 80 ~ 100 ℃ to increase the garlic porridge manufacturing process.
마늘에는 알리신이라는 성분과 알리나제라는 알리인을 분해 하는 효소가 포함되어 있으며 알리나제는 산소와 접촉하여 반응을 일으키게 된다. 이러한 반응을 통해서 알리인이 알리신으로 변화하고 이 과정에서 마늘 특유의 냄새가 나타나게 된다. 이렇게 생성된 알리신은 마늘의 주요 효능 물질로써 항균작용 및 고혈압 및 혈액순환 개선등의 유용한 작용을 하며 인슐린의 분비를 촉진시켜 당뇨를 예방하는데 효과가 있다. 하지만, 마늘에 생성된 알리신의 특유의 냄새와 맛으로 인하여 많이 섭취가 어려움으로 마늘을 이용한 식품을 제조하기 위해서는 알리신에 의한 맛과 냄새를 적정한 수준으로 조절하는 것이 필요한데 가열에 의한 알리신 분해가 가장 많이 쓰이고 있다. 그러나 마늘에 함유된 알리인이 알리신으로 변하기 전에 마늘을 통째 가열처리하면 알리인이 분해되어 알리신이 생성되지 않으므로 이에 본 발명의 제조공정에서는 증자 처리를 하기 전 알리신이 충분히 생성되도록 유도한 후 증자하여 마늘죽으로 제조하기 위하여 마늘을 분쇄하여 공기와 접촉하는 표면적을 증가시켜 알리나제와 산소의 접촉을 촉진시킴으로서 알리신의 생성을 최대화 하기 위하여 먼저 마늘을 선별하여 마늘의 껍질을 제거한 후 깨끗이 세척(수세)하여 물기를 제거한 다음 분쇄기로 분쇄하여 알리신이 충분히 생성되도록 유도한 후에 분쇄한 마늘을 80mesh 체로 곱게 거른 후 80~100℃에서 30분간 나무주걱으로 저어주면서 증자하여 마늘 죽을 제조하는 공정이다.Garlic contains an allicin and an enzyme that breaks down alysine, which is a lyase. Through this reaction, the aliin is changed to allicin, and in the process, the smell of garlic is revealed. Allicin thus produced is a main potent substance of garlic, and has a useful function of antibacterial action, high blood pressure and blood circulation improvement, and is effective in preventing diabetes by promoting insulin secretion. However, due to the peculiar smell and taste of allicin produced in garlic, it is difficult to consume a lot, so to prepare foods using garlic, it is necessary to adjust the taste and smell by allicin to an appropriate level. It is used. However, if the garlic is heat-treated before the allicin contained in the garlic is changed to allicin, the allin is decomposed and no allicin is produced. Therefore, in the manufacturing process of the present invention, the allicin is induced and then increased to increase the amount of allicin. To make garlic gruel, garlic is pulverized to increase the surface area in contact with air to promote contact between allinase and oxygen to maximize the production of allicin. After removing the water, and then crushed with a grinder to induce sufficient production of allicin, and then finely pulverized crushed garlic with 80 mesh sieve and stir with a wooden spatula for 30 minutes at 80 ~ 100 ℃ to prepare a garlic porridge.
2. 고추장 제조 단계2. Kochujang Manufacturing Step
2공정에서는, 제조되어진 마늘죽에 미리 준비한 엿질금을 혼합(마늘죽:엿질금=2:1)하는 1차 혼합 공정이며,In the second step, the prepared garlic gruel is a first mixing step of mixing previously prepared malt gold (garlic porridge: starch gold = 2: 1),
3공정에서는, 1차 혼합 공정에서 엿질금을 혼합한 마늘죽을 다시 나무주걱으로 저어주면서 80°C에서 약 20분간 증자하게 되는 공정이다.In the third step, the garlic porridge mixed with the malt in the first mixing step is stirred again with a wooden spatula, and the process is increased for about 20 minutes at 80 ° C.
4공정에서는. 증자된 원료에 고춧가루와 메주가루를 첨가하여 혼합하고 간 조절을 위하여 소금을 혼합하는 2차 혼합 공정이다.In four process. It is a secondary mixing process in which red pepper powder and meju powder are added and mixed with the cooked raw material and salt is mixed for liver control.
5공정에서는, 기호성 조절을 위해 소금, 감초, 치자, 홍화를 6 : 2 : 1 : 1의 비율로 혼합하였으며, 본 공정에서 사용한 소금은 천연소금으로서 마그네슘 등 각종 천연미네랄이 다량 함유되어 있을 뿐만 아니라 알칼리성으로 우리 전통식품 고유의 맛을 유지시켜 주는 특징을 갖고 있다. 또한 일반염 보다 우리 몸에 가장 적합하며 산화가 적다는 장점을 가지고 있으며, 감미의 목적으로 일반 고추장은 물엿이나 설탕을 첨가하지만 본 제조공정에서는 물엿이나 설탕 대신 천연물인 감초를 첨가하여 감미를 조절하였다. 물엿이나 설탕에서 기인한 당질은 단순당질로서 열량이 높은 반면 다른 영양소의 밀도가 낮은 특성을 가지고 있다. 따라서 섭취한 당질이 지방질로 바뀌어 체내 각 기관에 저장됨으로서 비만, 당뇨, 동맥경화 등의 성인병을 유발하게 된다.In step 5, salt, licorice, gardenia, and safflower were mixed in a ratio of 6: 2: 1: 1 to control palatability. The salt used in this process is a natural salt containing not only a large amount of various natural minerals such as magnesium, It is alkaline and keeps the taste unique to our traditional food. In addition, it has the advantage that it is most suitable for our body and less oxidation than general salt. For the purpose of sweetening, kochujang adds starch syrup or sugar, but in this manufacturing process, sweetness was adjusted by adding natural licorice instead of syrup or sugar. . Sugars derived from starch syrup or sugar are simple sugars and have high calories and low density of other nutrients. Therefore, the ingested sugar is converted into fat and stored in each organ in the body, causing adult diseases such as obesity, diabetes, arteriosclerosis.
그러나 본 공정에서 사용하는 감초는 천연물로서 인체내의 독을 중화 및 완화시키므로 한방 처방에서도 빠지지 않는 것으로 기퀴리친, 글루쿠로닉산, 글리씰하이직산, 글리씰하이진 등의 유효성분을 포함하고 있다. 이러한 성분 가운데 글리씰하이직산은 항알러지 작용과 인터페론 유리를 촉진시켜 항염작용 및 위산분비를 억제하고 위점막을 보호하는 항궤양작용을 하며 글리씰하이진은 기침과 가래를 그치게 하는 진해작용과 거담작용을 한다. 또한 부신피질호르몬처럼 근육의 긴장으로 인한 동통이나 신경의 긴장을 풀어주는 작용을 하며 탈 콜레스테롤 작용이 있어 동맥경화를 예방하고 유독물질을 해독하는 작용을 하므로 간장의 기능을 강화시킨다. However, licorice used in this process is a natural product, which neutralizes and alleviates the poison in the human body. Therefore, it does not fall out in herbal medicine, and it contains active ingredients such as giquiricin, glucuronic acid, glysilhijic acid, and glysyl heidizin . Among these ingredients, Glysylhijic Acid promotes anti-allergic and interferon release, inhibits anti-inflammatory and gastric acid secretion, and protects the gastric mucosa. It works. It also acts to relieve pain and nerve tension caused by muscle tension, like adrenal cortex hormones, and has a decholesterol action to prevent atherosclerosis and detoxify toxic substances, thus enhancing the function of the liver.
치자와 홍화는 고추장의 색택을 시각적으로 보기 좋게 하기 위해 첨가된 것으로 치자의 게니핀(genipin) 성분이 당뇨 유발과정을 환원시키는데 효과가 있어 당뇨로 인한 췌장 기능 장애를 예방할 수 있다. Gardenia and safflower are added to make kochujang more visually appealing, and the genipin component of gardenia is effective in reducing the diabetes-induced process, thus preventing pancreatic dysfunction caused by diabetes.
또한 홍화는 잇씨와 잇꽃으로 나뉘는데 잇씨는 칼슘과 미량 원소들이 많이 함유되어 있어 여성 호르몬의 역할을 대신하며 뼈질환에 좋으며 잇꽃은 여성들의 통경, 부인병에 효과적이다.In addition, safflower is divided into safflower and safflower. It contains calcium and trace elements, so it replaces the role of female hormone and is good for bone disease. Safflower is effective for women's pain and gynecological diseases.
이와 같이 감초, 치자, 홍화를 혼합하여 기호성 조절을 하게 되는 공정이다.As such, licorice, gardenia, safflower are mixed to control palatability.
6공정에서는, 상기의 1공정부터 5공정으로 제조되어진 고추장을 전통옹기에 담아 상온에서 숙성시키는 숙성단계의 마지막 공정을 거쳐 마늘고추장이 제조되어지는 것이다. In the sixth step, the garlic pepper paste is produced through the last step of the ripening step of putting the gochujang prepared in the step 1 to step 5 in the traditional Onggi aging at room temperature.
표 1은 본 발명인 마늘고추장의 재료 배합 비율을 나타낸 것으로, Table 1 shows the ingredients of the garlic pepper paste of the present invention,
표 1. 마늘고추장 제조에 사용한 재료 및 혼합비율
마늘고추장 제조에 사용한 재료 및 혼합비율은 다음과 같으며, 전체를 100%로 하였을 경우 고춧가루 45%, 마늘 20%, 메주가루, 15%, 엿질금 10%, 소금 6%, 감초 2%, 치자 1%, 홍화 1%를 첨가하여 제조한 것을 특징으로 하는 마늘 고추장에 관한 것이다. The ingredients and mixing ratios used in the preparation of garlic pepper paste are as follows, and when the whole is 100%,
상기의 공정들을 거쳐서 기호성과 건강기능성을 겸비한 마늘고추장을 공급할 목적으로 마늘의 건강기능효과를 최대한 살리면서 당 함량이 낮은 기능성 고추장의 제조를 시도하였고, 이것에 함유된 식품성분들을 분석하여 시판중인 일반고추장과 비교하였다. In order to supply garlic pepper paste with palatability and health function through the above process, we tried to manufacture functional red pepper paste with low sugar content while making the most of the health functional effect of garlic. It was compared with kochujang.
이를 실험예를 통하여 상세하게 설명하면 다음과 같다.This will be described in detail through an experimental example.
[실험예1] 본 발명인 마늘고추장 및 일반적인 시판고추장 성분 분석Experimental Example 1 Analysis of the Garlic Red Pepper Paste and Common Commercial Red Pepper Ingredients
1) 일반성분 분석1) General Ingredient Analysis
수분은 상압가열 건조법, 조단백질은 semicro kjedahl법, 조지방은 soxhlet법, 조회분은 건식회화법으로 정량하였다.Moisture was determined by atmospheric heating and drying, crude protein by semicro kjedahl method, crude fat by soxhlet method, and crude ash by dry painting method.
2) 조섬유2) crude fiber
건조 또는 탈지과정을 거친 시료에 대하여 한 시료 당 건조물 기준 0.2g의 시료를 취하여 AOAC 공정시험법으로 조섬유 함량을 측정하였다.A crude fiber content was measured by the AOAC process test method by taking a dry sample of 0.2g per sample on the dried or degreased samples.
시료를 예열된 1.25% H2SO4 200㎖에 정확히 30분 가열분해 시킨 후 여과(200mesh)하여 뜨거운 증류수로 수회 세척하고 다시 예열된 1.25% NaOH 200㎖에 정확히 30분 가열 분해시켰다. 항량을 구한 세라믹필터를 함유한 1G3여과용 유리도가니를 에탄올로 도가니 안의 세라믹필터를 적신 후 가열 분해물을 여과하여 뜨거운 증류수로 수회 세척한 후 다시 에탄올로 씻어내고 130℃ 전기오븐에서 2시간 건조시켰다. 데 시케이터에서 식힌 후 유리도가니 속의 침전물의 무게를 잰 후 525℃에서 30분 동안 회화시키고, 다시 데시케이터에서 식힌 후 회분량을 측정하여 침전물의 무게에서 빼어 조섬유 함량을 구하였다.The sample was pyrolyzed precisely for 30 minutes in 200 ml of preheated 1.25% H 2 SO 4 , filtered (200mesh), washed several times with hot distilled water, and then thermally decomposed exactly for 30 minutes in 200ml of preheated 1.25% NaOH. The 1G3 filtration glass crucible containing the obtained ceramic filter was wetted with ethanol, the ceramic filter in the crucible was filtered, and the thermally decomposed product was filtered and washed several times with hot distilled water. After cooling in a desiccator, the precipitate in the glass crucible was weighed and incubated at 525 ° C. for 30 minutes. After cooling in the desiccator, the ash content was measured and subtracted from the weight of the precipitate to obtain crude fiber content.
3) 총당 정량3) Quantification of total sugar
고추장의 총당은 페놀-황산(Phenol-H2SO4 ) 으로 정량하였다. 즉, 시료 10g에 70% 에탄올 200㎖를 가하여 80℃에서 2시간 환류냉각 추출하고, whatman No.2로 여과한 여액 1㎖에 5% 페놀 1㎖를 가한 다음, 진한 황산 5㎖를 가하여 혼합하고 15분간 방치한 후 분광광도계로 550nm에서 비색 측정하였다.The total sugar of kochujang was quantified by phenol-sulfuric acid (Phenol-H 2 SO 4 ) . That is, 200 ml of 70% ethanol was added to 10 g of the sample and reflux-cooled at 80 ° C. for 2 hours, 1 ml of 5% phenol was added to 1 ml of the filtrate filtered by whatman No. 2, and 5 ml of concentrated sulfuric acid was added and mixed. After standing for 15 minutes, the colorimetry was measured at 550 nm with a spectrophotometer.
4) 분석 결과4) Analysis result
일반성분 분석 결과로는, 마늘고추장과 시판고추장의 일반성분을 분석한 결과를 표 2에 나타내었다. 시판고추장과 마늘고추장의 단백질 함량은 각각 5.6%, 6.3% 이었고, 지방 2.9%, 2.6%, 회분 8.3%, 7.4%, 섬유질은 2.1%, 2.8%로 나타났다. 일반성분에 있어 시판고추장과 마늘고추장 간의 단백질, 지방, 회분 및 섬유질 함량은 큰 차이가 없이 비슷한 값으로 나타났으나 당질의 경우에는 시판고추장이 42.4% 마늘고추장이 22.0%로 나타나 시판고추장의 당 함량이 마늘고추장에 비해 약 2배정도 높은 것으로 나타났다. 이러한 원인은 시판고추장의 경우 고추장 재료로 호화전분을 사용하고 감미를 더하기 위하여 물엿이나 설탕 등을 첨가하지만 본 발명에서 제조한 마늘고추장의 경우 전분을 사용하지 않았기 때문이라 생각된다.As a result of the analysis of the general components, the results of analyzing the general components of garlic and commercial pepper paste are shown in Table 2. The protein contents of commercial and garlic pepper paste were 5.6% and 6.3%, respectively, and fats were 2.9%, 2.6%, ash 8.3%, 7.4% and fiber 2.1% and 2.8%, respectively. The protein, fat, ash and fiber contents of commercial and red pepper paste showed similar values without any significant difference in general ingredients, but in the case of sugar, 42.4% of garlic and 22.0% of red pepper paste showed sugar content It was about 2 times higher than the garlic pepper paste. The reason for this is that commercial starch uses luxury starch and adds starch syrup or sugar to add sweetness. However, garlic starch prepared in the present invention does not use starch.
당질은 인체의 대사과정에서 일차적으로 에너지로 이용되고 남은 당질은 글리코겐 이라는 지방질로 바뀌어 체내의 각 기관에 저장된다. 만일 사람이 고당질식이를 장기간 섭취하거나 운동부족이나 내분비계 이상으로 에너지 대사가 정상적으로 일어나지 못할 경우 계속하여 체내의 지방 축적이나 혈중 당 농도의 증가가 진행되게 되며 이것이 비만, 당뇨, 동맥경화 등과 같은 성인병을 유발하게 되는 것으로 알려져 있다.Carbohydrates are primarily used as energy in the body's metabolic processes, and the remaining sugars are converted into fats called glycogen and stored in each organ of the body. If a person consumes a high-glucose diet for a long time or if energy metabolism does not occur normally due to lack of exercise or endocrine system, the body continues to accumulate fat or increase blood glucose levels. This is caused by adult diseases such as obesity, diabetes, and arteriosclerosis. It is known to cause.
당질은 크게 단순당질과 복합당질로 나뉘며 단순당질에는 포도당, 과당 등의 단당류와 설탕, 맥아당, 유당 등의 이당류가 포함되며, 열량은 높으나 다른 영양소 밀도가 낮은 특성을 가지고 있다. 반면 복합당질은 식물성 식품에 많이 함유되어 있고, 필수지방산, 칼슘, 아연, 철분 및 비타민 등과 복합체를 이루고 있어 인체에 유익한 영양소 공급원으로 작용한다. 본 발명에서 제조한 마늘고추장은 시판고추장과 달리 단순당질의 주공급원이 되는 백미를 첨가하지 않음으로써 전체적인 당 함량은 낮으나 복합당질의 비율이 상대적으로 높아 오히려 인체에 유익한 역할을 할 것으로 추측된다.Sugars are largely divided into simple sugars and complex sugars. Simple sugars include monosaccharides such as glucose and fructose and disaccharides such as sugar, maltose and lactose, and have high calories but low density of other nutrients. Complex sugars, on the other hand, are found in plant foods and are complexed with essential fatty acids, calcium, zinc, iron, and vitamins, thus serving as a beneficial nutrient source for the human body. Garlic pepper paste prepared in the present invention, unlike commercially available pepper paste, does not add white rice, which is the main source of simple sugars, but the overall sugar content is low, but the ratio of the complex sugar is relatively high, and thus it is assumed that it will play a beneficial role in the human body.
[실험예 2] 본 발명인 마늘고추장 및 일반적인 시판고추장 유리아미노산 분석Experimental Example 2 Analysis of Free Amino Acids of Garlic Pepper and General Commercial Red Pepper
1) 유리아미노산 분석1) Free amino acid analysis
유리아미노산은 시료 5g에 5-sulfosalicylic acid 250㎎을 넣고 잘 혼합하여 균 질화 시켜 제 단백 시킨 후, 원심분리 (3,000×g. 15min) 한다. 상층액은 0.20㎛ membrane filter로 여과한 다음 리튬시트린산 완충액(pH 2.2)으로 일정량 희석하여 아미노산 자동 분석기(Hitachi model 835-50, Japan)로 분석하였다.The free amino acid is added to 250 g of 5-sulfosalicylic acid in 5 g of the sample, mixed well, homogenized and centrifuged (3,000 × g. 15 min). The supernatant was filtered with a 0.20 μm membrane filter and then diluted in a certain amount with lithium citrate buffer (pH 2.2) and analyzed with an amino acid automatic analyzer (Hitachi model 835-50, Japan).
2) 분석 결과2) Analysis result
시판고추장과 마늘고추장의 유리아미노산 분석결과는 표 3에 나타내었다. 시판고추장의 경우 전체 유리아미노산 함량 중에서 proline이 가장 높았으며 leucine, arginine, phenylalanine, alanine, glutamic acid 등의 순으로 함유되어 있는 것으로 나타났다. Table 3 shows the results of the analysis of free amino acids of commercial and garlic pepper pastes. In the case of commercial red pepper paste, proline was the highest among all the free amino acids and was found to contain leucine, arginine, phenylalanine, alanine, glutamic acid.
마늘고추장에서는 아르기닌(arginine)이 가장 높았고 글루타민산(glutamic acid), 발린(valine) 순으로 나타났다.Arginine was the highest in garlic pepper paste, followed by glutamic acid and valine.
유리아미노산 조성을 분석한 결과 시판고추장은 프로린(proline)을 제외하고는 전체적으로 고른 분포를 나타낸 반면 마늘고추장에서는 아르기닌(arginine)이 전체 유리아미노산 중 57.8%로 특이하게 높았고 상대적으로 다른 아미노산의 함량은 낮게 나타나는 경향을 보였다. 일반적으로 아미노산은 종류마다 독특한 맛을 지니고 있어 식품의 맛과 관계가 깊다. 특히 glutamic acid는 식품의 감칠맛을 내는데 결정적 역할을 하는 아미노산으로 알려져 있다. 본 발명에서 제조한 마늘고추장에 특이하게 많이 함유되어 있는 것으로 나타난 아르기닌(arginine)은 주로 두류에서 유래되는 것으로 인체에 여러 가지 유익한 효능을 나타낸다고 보고되고 있다.As a result of analysis of free amino acid composition, commercially available red pepper paste showed an even distribution except proline, whereas in garlic red pepper paste, arginine was uniquely high as 57.8% of all free amino acids and relatively low content of other amino acids. Showed a tendency. In general, amino acids have a unique taste for each type, and are closely related to the taste of food. In particular, glutamic acid is known as an amino acid that plays a decisive role in flavoring foods. Arginine, which has been shown to be specifically contained in the garlic pepper paste prepared in the present invention, is mainly derived from soybeans and has been reported to show various beneficial effects on the human body.
아르기닌(arginine)이 인체에 미치는 영향 중 가장 잘 알려져 있는 것은 심장질환에 효과가 있다는 것이다. 아르기닌(arginine)은 콜레스테롤을 효과적으로 감소시키는 기능이 탁월하여 관상동맥경화(심장마비)를 유발하는 응혈 생성을 억제하고, 동맥을 이완하여 혈액 순환이 원활하도록 하는 효과를 나타낸다고 보고되어 있다. 또한 아르기닌(arginine)은 근육 조직의 보존, 면역 기능 증강 및 남성 발기 유지에도 효과가 큰 것으로 나타나고 있어 본 발명에서 제조한 마늘고추장에 아르기닌(arginine) 특이적으로 많이 함유되어 있다는 사실은 주목할 만한 가치가 높다고 판단된다.The best known effect of arginine on the human body is its effectiveness in heart disease. Arginine has been reported to be effective in effectively reducing cholesterol, inhibiting the formation of blood clots causing coronary atherosclerosis (heart attack), and relaxing the arteries to facilitate blood circulation. In addition, arginine has been shown to be effective in preserving muscle tissue, enhancing immune function, and maintaining male erection, and thus, it is worth noting that the garlic pepper paste prepared in the present invention contains a lot of arginine. It is high.
또한 체내에서는 합성이 이루어지지 않아 음식으로 섭취해야 하는 필수아미노산으로 인체가 필요한 전체 아미노산의 절반을 차지하며 근육의 원료 물질이자 피로 회복과 활력 증진에 관여하는 valine의 함량과 콜라겐 생성을 촉진해 피부 노화를 억제하며 당뇨를 억제시키고 간 기능을 강화시키는 cystine의 함량이 시판고추장에 비해 마늘고추장에서 높게 나타났다. 그리고, 시판고추장에는 식품안정제로 많이 사용 되고 있는 proline과 감미성분인 glycine, 고미성분인 isoleucine, leucine, phenylalanine의 성분이 마늘고추장에 비해 높게 나타났다. 시판고추장에 높게 함유되어 있는 ammonium chloride는 오랜 체증으로 인해 배속에 덩어리가 생기는 증세와 굳은살을 없애고 새살이 돋아나게 하는 효과가 있으나 독성을 기지고 있어 많이 섭취하면 장과 위를 상하게 하므로 과다 섭취를 피하도록 권장하고 있다. In addition, since it is not synthesized in the body, it is an essential amino acid that must be consumed as a food, accounting for half of the total amino acids needed by the human body. The content of cystine, which inhibits diabetes mellitus and enhances liver function, was higher in garlic pepper paste than in commercial pepper paste. In addition, proline, sweetener glycine, and high-flavor isoleucine, leucine and phenylalanine were found to be higher in garlic than those in garlic. Ammonium chloride, which is high in commercial red pepper paste, has the effect of eliminating lumps and calluses in the stomach due to long periods of time, and sprouting new flesh. However, it is toxic and damages the intestines and stomach. It is recommended.
[실험예 3] 본 발명인 마늘고추장 및 일반적인 시판고추장 무기성분 분석Experimental Example 3 Analysis of Inorganic Components of the Garlic Pepper and General Commercial Red Pepper
1) 무기성분 분석1) Inorganic component analysis
무기성분분석은 식품공전 시험법(2002)에 따라서 습식분해법으로 시료를 조제하여 분석하였다. 즉, 시료 5g을 250㎖ 분해플라스크에 취하고 HNO3 10㎖를 넣어 가열하여 내용물을 건조시킨 후 HNO3용액 (HNO3 : H2O=1:2) 10㎖와 60% HClO4 10㎖를 넣고 무색이 될 때까지 가열하였다. 이어 소량의 증류수로 희석하여 증발접시에 옮기고 다시 가열하여 HClO4를 증발시킨 후 HCl용액 (HCl : H2O=1:2) 10㎖와 동량의 증류수로 희석하여 수욕 상에서 완전히 용해하고 100㎖로 정용하여 분석용 시료로 사용하였으며 원자흡광분광광도계를 이용하여 측정하였다. Inorganic component analysis was performed by preparing a sample by wet decomposition according to the Food Code (2002). That is, 5 g of the sample is taken in a 250 ml digestion flask and
2) 분석 결과2) Analysis result
시판고추장과 마늘고추장에 함유된 무기성분을 분석한 결과는 표 4에 나타내었다. Table 4 shows the results of analyzing the inorganic components in the commercial pepper paste and garlic pepper paste.
시료로 사용한 고추장 모두에서 Na, K, P의 함량이 높은 것으로 조사되었으며 시판고추장의 경우 Na 성분이 마늘고추장에 비해 약 12% 높게 나타났다. 이는 당 함량의 비교에서도 나타났듯이 시판고추장의 경우 제조공정상 첨가되는 곡물 유래 전분 함량이 높아 조미 외에도 초기 부패 방지의 목적으로 상당량의 식염을 첨가함에 반해 마늘고추장은 곡물 유래 전분이 첨가되지 않으므로 식염 첨가량을 일반적인 첨가량보다 낮게 할 수 있었기 때문이라 생각된다.The contents of Na, K, and P were high in all the red pepper pastes used as samples, and Na content was about 12% higher than garlic pepper paste. As shown in the comparison of sugar content, the commercially produced red pepper paste has a high content of grain-derived starch, which is added during the manufacturing process, while the garlic red pepper paste does not contain starch-derived grains. It is thought that it was because it was made lower than general addition amount.
일반적으로 고추장 제조에 있어서 조미와 보존의 목적으로 식염을 첨가하게 되는데 Na은 삼투압 조절기능을 통해 체액의 균형을 유지하는 유용한 기능을 가지고 있는 반면 일정량 이상 섭취 시 혈압 상승 및 당뇨병의 원인이 될 수도 있는 무기성분이다.Generally, salt is added in the preparation of kochujang for the purpose of seasoning and preservation. Na has a useful function of maintaining the balance of body fluid through the osmotic pressure control function. It is an inorganic ingredient.
Na 다음으로 높은 함량을 나타낸 K의 생리작용은 에너지의 방출과 글리코겐의 합성, 단백질의 합성에 있어서 촉매역할을 하는 것으로 알려져 있으며, 고혈압을 유발하는 Na의 과잉섭취 시 Na을 제거하는 작용도 있는 것으로 알려져 있다. 그러나 일정량 이상으로 Na의 섭취가 많아지면 K의 촉매효과는 감소되어 세포대사 특히 단백질 합성에 방해가 일어나는 것으로 알려져 있다.The physiological action of K, which has the highest content after Na, is known to play a catalytic role in the release of energy, the synthesis of glycogen, and the synthesis of protein, and it also removes Na during the excessive intake of Na causing high blood pressure. Known. However, if the intake of Na in more than a certain amount is reduced the catalytic effect of K is known to interfere with cell metabolism, especially protein synthesis.
마늘고추장이 시판고추장에 비해 P의 함량이 높은 것으로 나타났는데 P은 뼈와 이를 구성하는 성분이며 인지질 핵산으로 모든 조직을 구성하는 역할을 하는 것으로 알려져 있다. 그리고 성장기 어린이들의 발육에 유용한 작용을 하는 Ca과 Fe도 마늘고추장이 높은 것으로 조사되었다.Garlic pepper paste has higher P content than commercial pepper paste. P is a component of bone and it is known to play a role in constituting all tissues with phospholipid nucleic acid. In addition, Ca and Fe, which are useful for growing children, are also high in garlic pepper paste.
이상의 결과 마늘고추장의 경우 인체에 유해한 작용을 할 수 있는 무기성분의 함량은 낮은 대신 유용한 무기성분이 시판고추장보다 높은 것으로 확인되었다.As a result, in the case of garlic pepper, the content of inorganic ingredient which can have a harmful effect on human body is low, but it is confirmed that useful inorganic ingredient is higher than commercial pepper paste.
[실험예 4] 마늘고추장 및 일반적인 시판고추장 비타민 분석Experimental Example 4 Analysis of Vitamins of Garlic and Gochujang
1) 비타민 A의 정량1) Quantification of Vitamin A
비타민A의 정량은 삼엽화 안티몬에 의한 정량법에 따라 분석하였다. 조제한 고추장 시료를 이용하여 클로로포름을 대조구로 하여 보정하고 대조액으로 클로로포름 0.3 ㎖, 시료액 0.3㎖를 각각의 셀에 취한 후 삼염화안티몬/클로로포름 용액 3㎖를 각각의 셀에 첨가하고 620nm에서 15초 내에 흡광도를 측정하고 작성한 검량선을 이용하여 비타민 A를 정량한다.Quantification of vitamin A was analyzed according to the quantification method by trifoliated antimony. Using the prepared kochujang sample, chloroform was corrected as a control, 0.3 mL of chloroform and 0.3 mL of sample solution were added to each cell as a control solution, and then 3 mL of antimony trichloride / chloroform solution was added to each cell. Measure and quantify vitamin A using the calibration curve.
2) 비타민 B1의 정량2) Determination of Vitamin B1
비타민 B1의 정량은 HPLC를 이용하여 측정하였으며 방법은 다음과 같다. 시료 1g을 10% 삼염화아세트산에서 균질화한 후 9,000 rpm으로 원심분리한다. 상징액을 취해 4M 아세트산나트륨용액을 가하여 pH 4.5-4.7이 되게 하고 2% takadiastase를 가한 후 37℃에서 10시간 방치한 후 분석한다. Column은 비타민 B1분리용을 사용하고, 이동상은 0.1M 인산나트륨용액을 사용한다. Quantification of vitamin B1 was measured using HPLC and the method is as follows. 1 g of sample is homogenized in 10% trichloroacetic acid and centrifuged at 9,000 rpm. Take supernatant, add 4M sodium acetate solution to pH 4.5-4.7, add 2% takadiastase, and leave for 10 hours at 37 ℃ for analysis. The column is used for the separation of vitamin B1, and the mobile phase uses 0.1M sodium phosphate solution.
3) 비타민 B2의 정량3) Determination of Vitamin B2
비타민 B2의 정량은 HPLC를 이용하여 측정하였으며 방법은 다음과 같다. 일정량의 시료에 소량의 물을 가하여 균질화 한 후 적당량을 물을 가하여 70-80℃의 수조에서 15분 추출한 후 HPLC로 분석하였으며 Column은 액상분배형을 사용하였으며 이동상은 Methanol/10mM Na2H2PO4 용액(pH 5.5)(35:65)을 사용하였다.Quantification of vitamin B2 was measured using HPLC and the method is as follows. After homogenizing by adding a small amount of water to a certain amount of sample, an appropriate amount of water was extracted for 15 minutes in a water bath at 70-80 ° C, and analyzed by HPLC. The column was liquid-distributed and the mobile phase was Methanol / 10mM Na 2 H 2 PO. 4 solution (pH 5.5) (35:65) was used.
4) 비타민 C 정량4) Vitamin C Quantification
비타민 C 정량은 시료 5g에 동량의 2% metaphosphoric acid 용액을 가하여 균질화 한 후 2% metaphosphoric acid 용액으로 100㎖로 정용하여 12,000rpm에서 5분간 원심분리한 후 whatman No.% 여과지로 흡입여과한 다음 희석하여 측정용 시료로 사용하였으며, 2,4-dinitrophenol hydrazine(DNP) 비색법으로 측정하였다. 총 비타민 C 는 시료액 2㎖에 indophenol 0.2㎖, metaphosphoric acid 혼액 2㎖를 넣어 충분히 혼합하고 여기에 DNP 1㎖를 가하여 50℃에서 1시간 10분 반응시킨 즉시 방냉한 후 85% H2SO4 용액 5㎖를 voltes상에서 가하여 실온에서 30분간 방치, 540nm에서 흡광도를 측정하였다. 산화형 비타민 C는 indophenol을 제외하고 나머지는 동일한 방법으로 흡광도를 측정하였다.To quantify vitamin C, homogenize the solution by adding the same amount of 2% metaphosphoric acid solution to 5 g of the sample. It was used as a sample for measurement, it was measured by 2,4-dinitrophenol hydrazine (DNP) colorimetric method. Total vitamin C is a sample solution 2㎖ indophenol 0.2㎖, metaphosphoric acid mixture to be mixed thoroughly and put 2㎖ ml of DNP 1㎖ here that immediately after 70 minutes reaction at 50 ℃ cooling solution in 85% H 2 SO 4 5 ml was added on voltes, left at room temperature for 30 minutes, and absorbance was measured at 540 nm. Oxidative vitamin C was absorbed except for indophenol.
5) 분석 결과5) Analysis result
마늘고추장과 시판고추장의 비타민 함량을 분석한 결과(표 5) 두 시료 모두 비타민 A 함량이 각각 328, 392로 가장 높게 나타났다. 이는 비타민 A가 많이 함유된 것으로 알려진 치즈나 계란의 함량과 비슷하며, 비타민 A는 지용성 비타민으로 시력을 보호하고 점막을 정상으로 유지하며 병의 회복과 성장을 돕는 기능을 가지고 있는 것으로 알려져 있다. 비타민 B1과 B2는 시판고추장과 마늘고추장 모두 매우 낮게 나타났다. 비타민 C의 경우 시판고추장이 3.7mg% 마늘고추장이 1.5mg% 함유되어 있는 것으로 조사되었다.As a result of analyzing the vitamin content of garlic and commercial red pepper paste (Table 5), the vitamin A content of both samples was 328 and 392, respectively. It is similar to the content of cheese or eggs, which are known to be high in vitamin A. Vitamin A is a fat-soluble vitamin that is known to protect eyesight, keep mucous membranes normal, and help to recover and grow disease. Vitamin B1 and B2 were very low in both commercial and garlic pepper paste. Vitamin C was found to contain 3.7mg% of commercial pepper paste and 1.5mg% of garlic pepper paste.
[실험예 5] 마늘고추장 및 일반적인 시판고추장 GC-MASS를 이용한 질량분석Experimental Example 5 Mass Spectrometry Using Garlic Chili Pepper and General Commercial Chili Pepper GC-MASS
1) 질량 분석1) mass spectrometry
고추장성분의 질량분석은 GC/MS (Shimadzu, Japan, QP-5050A)를 이용하여 마늘고추장을 대상으로 질량 분석 하였다.Mass spectrometry of kochujang component GC / MS (Shimadzu, Japan, QP-5050A) was used to perform mass spectrometry on garlic pepper paste.
2) 분석 결과2) Analysis result
마늘의 자극적인 냄새와 맛은 알리신이라는 물질에 의해 발현되는데 이는 마늘에 들어 있는 알리인이 공기 중의 산소와 반응하여 합성된 것이다. 이러한 알리신은 항암효과, 당뇨 및 고혈압 개선, 해독작용, 자양강장 등과 같은 인체에 유익한 기능이 많다고 알려져 있다. 그러나 앞에서 언급하였듯이 그 맛과 냄새가 강하여 다량섭취가 어려운 단점이 있다. 그러므로 마늘을 이용한 식품을 제조하기 위해서는 알리신에 의한 맛과 냄새를 적정한 수준으로 조절하는 것이 필요한데 가열에 의한 알리신 분해가 가장 많이 쓰이고 있다. 그러나 마늘에 함유된 알리인이 알리신으로 변하기 전에 마늘을 통째 가열처리하면 알리인이 분해되어 알리신이 생성되지 않으므로 가열 처리를 하기 전 마늘을 분쇄하여 알리신이 충분히 생성되도록 유도한 후 가열하는 것이 효과적 처리방법이라 하겠다. 마늘에는 알리신 다음으로 중요한 물질이 함유되어 있는데 이것이 설파이드계 화합물이다. 즉, 함황화합물인 diallyl disulfide, diallyl trisulfide, diallyl tetra sulfide가 그것으로 이들도 공기와의 접촉에 의해서 발현되는 화합물이며, 암발생 억제, 고혈압 및 당뇨 개선 효과가 대표적이며 열에도 비교적 안정한 것으로 보고되어 있다. 마늘의 설파이드계 화합물 전구체에 대해서는 아직 정확히 밝혀져 있지는 않으나 일반적으로 황을 함유하는 아미노산인 메치오닌(methionine)과 시스테인(cysteine)이 전구체 역할을 할 것으로 추측하고 있다.Garlic's irritating smell and taste are expressed by a substance called allicin, which is synthesized by the reaction of allicin in garlic with oxygen in the air. Allicin is known to have many beneficial functions such as anticancer effect, diabetes and hypertension improvement, detoxification, nourishing tonic and so on. However, as mentioned earlier, its taste and smell are strong, so it is difficult to consume large amounts. Therefore, in order to manufacture foods using garlic, it is necessary to control the taste and smell by allicin to an appropriate level, and the decomposition of allicin by heating is most commonly used. However, if the garlic is heat-treated before the allicin contained in the garlic is changed to allicin, the allin is decomposed and no allicin is produced. Therefore, it is effective to induce sufficient production of allicin by pulverizing the garlic before the heat treatment. It's a way. Garlic contains the next most important substance, allicin, which is a sulfide compound. In other words, sulfur-containing compounds such as diallyl disulfide, diallyl trisulfide, and diallyl tetra sulfide are also compounds that are expressed by contact with air, and it is reported that cancer suppression, hypertension and diabetes improvement effect are representative and heat stable. . The sulfide compound precursors of garlic are not known yet, but sulfur-containing amino acids, methionine and cysteine, are assumed to act as precursors.
본 발명에서 제조한 마늘고추장의 제조 공정은 마늘의 유익한 성분을 최대한 유지하기 위하여 먼저 마늘을 분쇄한 후 가열 처리하였다. 이후 가열과 발효 과정을 거친 후에도 이들 화합물들이 남아 있는지 여부를 확인하기 위하여 질량분석기를 이용하여 분석한 결과는 도 2에 도시한 바와 같다.In the manufacturing process of the garlic pepper paste prepared in the present invention, in order to maintain the beneficial components of garlic to the maximum, the garlic was first ground and then heat treated. After the heating and fermentation process, the results of the analysis using a mass spectrometer to check whether these compounds remain as shown in FIG.
도 2에서 나타난 바와 같이 마늘고추장에 분자량 146인 diallyl disulfide (C6H10S2)와 178인 diallyl trisulfide(C6H10S3)가 존재하는 곳으로 확인되었으며, 특히 diallyl disulfide가 많이 함유되어 있는 것으로 나타났다. 이는 제조과정에서 마늘을 먼저 분쇄한 후 가열처리한 효과에 의한 것이라 생각된다.As shown in FIG. 2, it was confirmed that the garlic pepper paste contains a diallyl disulfide (C 6 H 10 S 2 ) having a molecular weight of 146 and a diallyl trisulfide (C 6 H 10 S 3 ) having a molecular weight of 178, and particularly contains a lot of diallyl disulfide. Appeared to be. This is thought to be due to the effect of heat treatment after grinding the garlic first in the manufacturing process.
그러므로, 상기의 비교 분석 실험예들로 얻어진 결과에 따르면, 마늘고추장과 시판고추장의 일반성분에 있어서는 시판고추장과 마늘고추장 간의 단백질, 지방, 회분 및 섬유질 함량은 큰 차이가 없이 비슷한 값으로 나타났으나 당질의 경우에는 시판고추장이 42.4% 마늘고추장이 22.0%로 나타나 시판고추장의 당 함량이 마늘고추장에 비해 약 2배정도 높은 것으로 나타났으며,Therefore, according to the results obtained by the comparative analysis experiment examples, the protein, fat, ash, and fiber content of the commercial pepper paste and garlic pepper paste showed similar values without any significant difference in the general ingredients of garlic and commercial pepper paste. In the case of carbohydrate, 42.4% of garlic pepper paste was 22.0%, and the sugar content of commercial pepper paste was about 2 times higher than that of garlic pepper paste.
유리아미노산 조성에서 시판고추장은 프로린(proline)을 제외하고는 전체적으로 고른 분포를 나타낸 반면 마늘고추장에서는 아르기니(arginine)이 전체 유리아미노산 중 57.8%로 특이하게 높았고 상대적으로 다른 아미노산의 함량은 낮게 나타나는 경향을 보였다.In the free amino acid composition, commercially available red pepper paste showed a uniform distribution except proline, whereas in garlic red pepper, arginine was particularly high as 57.8% of all free amino acids, and the content of other amino acids was low. Showed.
시료로 사용한 고추장 모두에서 Na, K, P의 함량이 높은 것으로 조사되었으며 시판고추장의 경우 Na 성분이 마늘고추장에 비해 높게 나타났다. 이는 시판고추장의 경 우 제조공정상 첨가되는 곡물 유래 전분 함량이 높아 조미 외에도 초기 부패 방지의 목적으로 상당량의 식염을 첨가함에 반해 마늘고추장은 곡물 유래 전분이 첨가되지 않으므로 식염 첨가량을 일반적인 첨가량보다 낮게 할 수 있었기 때문이라 결론을 도출할 수 있었으며. 마늘고추장과 시판고추장의 비타민 함량을 분석한 결과는 두 시료 모두 비타민 A 함량이 가장 높게 나타났다. 이는 비타민 A가 많이 함유된 것으로 알려진 치즈나 계란의 함량과 비슷한 수준이었다.The contents of Na, K, and P were high in all the red pepper pastes used as samples, and the Na content of commercial red pepper paste was higher than that of garlic pepper paste. This is due to the high content of grain-derived starch added during the manufacturing process in the case of commercially prepared red pepper paste, while the salt added to the garlic pepper paste is lower than the general amount because garlic starch is not added to the starch. Because I was able to draw conclusions. As a result of analyzing the vitamin content of garlic and commercial pepper paste, vitamin A content was the highest in both samples. This is similar to the cheese or egg content known to be high in vitamin A.
질량분석 결과를 통하여 본 발명의 방법으로 제조한 마늘고추장에 항암, 고혈압 및 당뇨 개선에 효과가 높은 것으로 알려져 있는 설파이드계 화합물이 함유되어 있음이 확인되었다.Through mass spectrometry results, it was confirmed that the garlic pepper paste prepared by the method of the present invention contained sulfide-based compounds which are known to have high effect on anticancer, hypertension and diabetes improvement.
이상의 결과를 종합해 볼 때 본 발명에서 제조한 마늘고추장은 최근 사람들의 관심이 집중되고 있는 웰빙 식품으로서 매우 적합한 조건을 고루 갖추고 있다고 사료되었다.In conclusion, the garlic red pepper paste prepared in the present invention is considered to have very suitable conditions as well-being foods that have recently been attracting attention.
이상에서와 같이 본 발명은 비록 상기에 한하여 설명하였지만 반드시 여기에만 한정되는 것은 아니며 본 발명의 범주와 사상을 벗어나지 않는 범위 내에서 다양한 변형실시가 가능함은 물론이다.As described above, although the present invention has been described above, it is not necessarily limited thereto, and various modifications may be made without departing from the scope and spirit of the present invention.
전술한 구성 및 작용에 의한 효과를 상세하게 설명하면 다음과 같다. Referring to the effects of the above-described configuration and operation in detail as follows.
상기 실시예를 통해 살펴본 바와 같이, 본 발명에 의해 제조된 마늘고추장은 마늘 의 고유의 성분 및 건강기능 효과를 최대한 극대화 하면서 전분을 사용하지 않음으로 인한 당 함량과 염이 낮은 고추장으로서 기호성과 건강기능성을 겸비하여 자양강장, 항암, 고혈압 및 당뇨 개선에 효과를 자연스럽게 얻을 수 있는 것이다. As seen through the above embodiment, the garlic pepper paste prepared by the present invention is a red pepper paste with low sugar content and salt due to not using starch while maximizing the intrinsic ingredients and health function effects of garlic, and palatability and health functionalities. By combining nourishing tonic, anti-cancer, hypertension and diabetes, the effect will be naturally obtained.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060074668A KR100760983B1 (en) | 2006-08-08 | 2006-08-08 | A red pepper paste added garlic and its making method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060074668A KR100760983B1 (en) | 2006-08-08 | 2006-08-08 | A red pepper paste added garlic and its making method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100760983B1 true KR100760983B1 (en) | 2007-10-04 |
Family
ID=39418572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060074668A KR100760983B1 (en) | 2006-08-08 | 2006-08-08 | A red pepper paste added garlic and its making method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100760983B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100932474B1 (en) * | 2008-02-29 | 2009-12-17 | 경기도 | Feed composition for sturgeon containing garlic extract |
CN102670788A (en) * | 2012-05-11 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic constipation |
KR101600309B1 (en) * | 2014-12-26 | 2016-03-21 | 손수영 | the manufacturing method of gochujang with garlic |
KR20160062943A (en) | 2014-11-26 | 2016-06-03 | 김홍자 | Garlic mixed with red pepper paste and Manufacturing method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010074596A (en) * | 2001-05-09 | 2001-08-04 | 류희영 | Hot pepper paste adding garlic therein and the manufacturing method thereof |
-
2006
- 2006-08-08 KR KR1020060074668A patent/KR100760983B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010074596A (en) * | 2001-05-09 | 2001-08-04 | 류희영 | Hot pepper paste adding garlic therein and the manufacturing method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100932474B1 (en) * | 2008-02-29 | 2009-12-17 | 경기도 | Feed composition for sturgeon containing garlic extract |
CN102670788A (en) * | 2012-05-11 | 2012-09-19 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic constipation |
KR20160062943A (en) | 2014-11-26 | 2016-06-03 | 김홍자 | Garlic mixed with red pepper paste and Manufacturing method |
KR101600309B1 (en) * | 2014-12-26 | 2016-03-21 | 손수영 | the manufacturing method of gochujang with garlic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103340385B (en) | Multi-functional health care soy sauce and preparation method thereof | |
CN101513246A (en) | Yeast extract, preparation method and application thereof | |
CN104041799A (en) | Bamboo sprout chili sauce and preparation method thereof | |
KR100760983B1 (en) | A red pepper paste added garlic and its making method | |
KR101027309B1 (en) | Oyster extract addition Dressing for vegetables | |
CN101569425A (en) | Passion fruit vinegar liquid and preparation method thereof | |
KR20130071708A (en) | Spicy sauce composition for spicy chicken and method for preparing thereof | |
CN108208756A (en) | A kind of Chinese chestnut mushroom sauce and preparation method thereof | |
KR101083524B1 (en) | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup | |
CN104431434A (en) | Bean residue fermented formula chicken feed and preparation method thereof | |
CN103284244B (en) | Garlic juice beverage and preparation method thereof | |
KR100495986B1 (en) | Red pepper paste composition and its method of preparation | |
KR100336650B1 (en) | The composites of raw-type tea with the function of activating the brain and promoting the growth | |
KR20100063936A (en) | Thick soypaste mixed with red pepper and polymnia sonchifolia | |
CN104304379A (en) | Health-care fresh-keeping biscuits capable of assisting in lowering blood glucose and production method thereof | |
KR101111288B1 (en) | Functional red pepper paste and manufacturing method thereof | |
CN110214893A (en) | Full nutritious food of linseed bean powder and preparation method thereof | |
KR100701869B1 (en) | Method for preparing treated gallic and garlic food containing the same | |
CN103494054B (en) | Mud snail vermicelli and production method thereof | |
CN108497087A (en) | A kind of Se-enriched yeast bean powder | |
KR100408805B1 (en) | Candy containing bamboo salt and red flower seed | |
CN106690062A (en) | Crisp garlic chips and processing method thereof | |
KR20030009782A (en) | Method of producing a healthy Apple Gochujang (hot pepper paste) | |
KR100804409B1 (en) | Process for making dumpling using sulfur duck | |
KR20070107621A (en) | Natural foods for increasing physical strength comprising a lees of raw rice wine or an extract of the lees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120903 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130911 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140915 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150908 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160823 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170907 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180809 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190904 Year of fee payment: 13 |